Source - LSE Regulatory
RNS Number : 1143W
Bodycote PLC
20 December 2021
 

20 December 2021

Bodycote plc

Appointment of Non-Executive Chairman

 

Bodycote plc is pleased to announce that it has appointed Daniel Dayan as Non-Executive Chair with effect from 1 January 2022. Daniel will succeed Anne Quinn CBE who, as announced on 27 May 2021, informed the Board of her intention to retire as Chair and step down from the Board as part of an orderly transition once a suitable successor had been identified.

 

Daniel brings a wealth of international industrial manufacturing and public company experience to Bodycote. Daniel is currently Chairman of CellMark AB, the Swedish supply chain services and industrial materials distribution company. He has previously held positions as Chairman of Low & Bonar plc and Non-Executive Director of Chemring Group plc.

 

In his executive career he was CEO of Fiberweb plc, the international specialty industrial and construction materials business, for eight years, leading the business through its demerger from BBA Aviation in 2006, until its acquisition and delisting in 2013. He has more recently been CEO of global packaging groups, Linpac and Klöckner Pentaplast. Daniel spent his early career at Novar plc until 2005, where he held a number of executive positions including Chief Executive of the Intelligent Building Systems Division. Prior to that, Daniel worked at ICI and management consultant, Arthur D Little. He holds a bachelor's degree in Engineering, from the University of Cambridge.

 

 

For further information, please contact:

FTI Consulting

Richard Mountain / Susanne Yule

Tel No +44 (0) 2037271340

 

About Bodycote

With more than 165 accredited facilities in 22 countries, Bodycote is the world's largest provider of heat treatment and specialist thermal processing services. Bodycote improves the properties of metals and alloys for a wide range of manufacturing industries. Customers in these industries have entrusted their products to Bodycote's care for more than 30 years. For more information, visit

www.bodycote.com.

 

Notes

A full list of Daniel's current and past Directorships is below:

 

Current Directorships

CellMark AB, Chair (2021-date)

 

Past Non-Executive Directorships

Low & Bonar plc, Chair (2018-2020)

Chemring Group plc, Non-Executive Director (2016-2018)

Nonwovens Innovation & Research Institute, Chair (2014-2015)

 

9.6.11R and 9.6.13R of the Listing Rules of the UK Listing Authority

This notice is given in fulfilment of the obligation under paragraph 9.6.11R of the Listing Rules. There are no further details that are required to be disclosed in respect of Daniel Dayan's appointment under paragraph 9.6.13 of the Listing Rules.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOATLBFTMTMBBJB
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJ Bell logo

Related Charts

Bodycote PLC (BOY)

-6.00p (-0.87%)
delayed 07:53AM